Compare CPRX & BKV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CPRX | BKV |
|---|---|---|
| Founded | 2002 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.8B |
| IPO Year | 2006 | 2024 |
| Metric | CPRX | BKV |
|---|---|---|
| Price | $24.17 | $26.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 7 |
| Target Price | ★ $32.60 | $30.29 |
| AVG Volume (30 Days) | ★ 1.2M | 1.1M |
| Earning Date | 11-05-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 44.94 | N/A |
| EPS | ★ 1.71 | 0.53 |
| Revenue | $578,196,000.00 | ★ $822,525,000.00 |
| Revenue This Year | $19.87 | $50.73 |
| Revenue Next Year | $7.21 | $43.23 |
| P/E Ratio | ★ $13.83 | $54.02 |
| Revenue Growth | 25.56 | ★ 33.41 |
| 52 Week Low | $19.05 | $15.00 |
| 52 Week High | $26.58 | $29.65 |
| Indicator | CPRX | BKV |
|---|---|---|
| Relative Strength Index (RSI) | 66.20 | 49.87 |
| Support Level | $22.67 | $28.01 |
| Resistance Level | $23.84 | $29.25 |
| Average True Range (ATR) | 0.68 | 1.12 |
| MACD | 0.01 | -0.15 |
| Stochastic Oscillator | 70.80 | 40.47 |
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).
BKV Corp is a growth-driven energy company. Its core business is production of natural gas from its owned and operated upstream businesses. It operates in four business lines: natural gas production, natural gas gathering, processing and transportation (natural gas midstream business), power generation and carbon capture, utilization, and sequestration (CCUS).